17 Hanover Square
London W1S 1BN
United Kingdom
44 91 7900 9829
https://www.plandaibiotech.com
Settore/i: Financial Services
Settore: Shell Companies
Impiegati a tempo pieno: 180
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Roger Baylis-Duffield | Co-Founder, Chairman and Chief Executive Officer | 180k | N/D | 1943 |
Mr. Callum Baylis-Duffield | President, Chief Operating Officer and Director | 120k | N/D | 1985 |
Mr. Ezra Jones | Vice President of Sales and Marketing | N/D | N/D | N/D |
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
L'ISS Governance QualityScore di Plandaí Biotechnology, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.